about
Treatment of myoclonusCaV3.2 calcium channels control NMDA receptor-mediated transmission: a new mechanism for absence epilepsy.Altered expression and assembly of N-type calcium channel alpha1B and beta subunits in epileptic lethargic (lh/lh) mouseExcitatory but not inhibitory synaptic transmission is reduced in lethargic (Cacnb4(lh)) and tottering (Cacna1atg) mouse thalamiInvolvement of the Thalamocortical System in Epileptic Loss of ConsciousnessThe pathological substrate of limbic epilepsy: neuronal loss in the medial dorsal thalamic nucleus as the consistent change.A gain in GABAA receptor synaptic strength in thalamus reduces oscillatory activity and absence seizures.Deletion of phospholipase C beta4 in thalamocortical relay nucleus leads to absence seizures.Childhood absence epilepsy: genes, channels, neurons and networks.Cellular and network mechanisms of spike-wave seizures.Gamma-hydroxybutyric acid: an emerging recreational drug.Control of Absence Seizures by the Thalamic Feed-Forward Inhibition.The pharmacologic basis of antiepileptic drug action.Association analysis of exonic variants of the gene encoding the GABAB receptor and idiopathic generalized epilepsy.Maturational aspects of epilepsy mechanisms and consequences for the immature brain.Transition to absence seizures and the role of GABA(A) receptorsSelection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed.Generalized epileptic disorders: an update.EFNS guideline on the management of status epilepticus in adults.The neurobiology and consequences of epilepsy in the developing brain.Corticothalamic modulation during absence seizures in rats: a functional MRI assessmentAnimal models of absence epilepsies: what do they model and do sex and sex hormones matter?Novel anticonvulsant medications in development.Is plasticity of GABAergic mechanisms relevant to epileptogenesis?Shared mechanisms of antidepressant and antiepileptic treatments: drugs and devices.Disinhibition-induced transitions between absence and tonic-clonic epileptic seizuresMechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects.Clinical and neurophysiologic spectrum associated with atypical absence seizures in children with intractable epilepsy.Stargazer--a mouse to seize!Epilepsy: a review of selected clinical syndromes and advances in basic science.EFNS guideline on the management of status epilepticus.Choosing the correct antiepileptic drugs: from animal studies to the clinic.Cerebellar output controls generalized spike-and-wave discharge occurrence.A role for the preoptic sleep-promoting system in absence epilepsy.Stimulus-induced Epileptic Spike-Wave Discharges in Thalamocortical Model with Disinhibition.T-type Ca2+ channels in absence epilepsy.GABA(B) receptor isoforms GBR1a and GBR1b, appear to be associated with pre- and post-synaptic elements respectively in rat and human cerebellum.Microbial Proteins as Novel Industrial Biotechnology Hosts to Treat Epilepsy.Block of Thalamic T-Type Ca(2+) Channels by Ethosuximide Is Not the Whole Story.The current state of absence epilepsy: can we have your attention?
P2860
Q27025673-4E980BC7-7E0B-4AFD-AA30-67F71BF5DF44Q27323026-DC37D4A7-C370-4659-AA6A-59C4FCCC254CQ28587315-F69CA601-AB82-4B3D-AC51-57E1F245ECEDQ28590366-6AEE1E70-5F94-478B-910A-2350F32488D3Q29042405-AF15E914-737D-4619-A7DA-70C3BF285A43Q30306125-EEF95E50-D760-47A2-8A81-7729E9FC38EFQ30487472-17827CA4-CE4B-4662-912B-BC4734ABBDB7Q30492598-382C9997-ECEA-46FA-B0D3-CB4207DF09A7Q30835420-12B8E27F-CD0F-4F0E-902B-02FD6638A2BCQ33227648-15D15CFC-B399-4089-822F-B6BBB57B81FBQ33588063-E697F3D9-FA10-44AB-A902-B77F9C503CBAQ33603563-3DC7711F-4EFE-409C-A512-425A0541E488Q33775706-0D0FD86A-DCA9-46CF-A74F-F0707400832EQ33867724-B13CB792-B996-47B4-908B-0D3757624462Q33948820-A22168C4-D6E2-45E8-8E25-C6D858C0188EQ34010417-FB9BD73D-5772-4AED-B437-8FF949F31112Q34082054-3D59BF25-3DDE-4540-A908-E6A283D04B76Q34083112-55425B0E-E908-4322-A92C-810C25D2CA4BQ34091095-E8494FE6-0E25-454D-803B-26A95D03CE04Q34167901-36D3B55E-0EF2-47D3-AFA3-B722467EE3CBQ34234724-A14026FA-1EA8-476B-AE19-AD2067BBA448Q34615606-814801C2-8CA7-44E5-A0A8-6538E36330A2Q34974862-6D2CA9DB-E30B-409B-911C-9A968D8DC5FFQ35207594-3E8DA48B-1C0F-4555-BB16-FE5380001D33Q35757922-7A7B036B-0C4C-4BE1-952A-598631F84C23Q35902032-CF6C7089-2C84-42BF-91EF-C3604A39E9C4Q35939580-E472CFF8-D5F6-4844-894E-9BDAE95DEE4FQ36169617-1A3F0C34-6352-432C-BEA8-BB59D976E86DQ36263033-CDF0577E-3ABC-46DD-A6FA-87685A294458Q36377765-E454976E-605F-4E5E-BB3C-B8A04F74E496Q36488352-F537FC93-6736-4551-AE77-28E3924A7EA9Q37086272-A91AADB1-DE98-40E1-BF8E-65888242D9A6Q37225086-88010119-962E-4EC8-A88F-437493FC4233Q37375306-0AF0AB06-CDBB-4B9C-8D74-B698F1D11BB4Q37431118-E1FAE495-DBF1-4354-BA32-2031652F72DCQ38187360-25A3FC82-050C-4D95-87EB-B58EF0C114F7Q38325448-D8A544AA-3FB8-4F2C-B77D-25D9B80FA2CFQ39025252-E0E85DBB-E6DA-4E12-A2EC-EEF86B57777FQ40466161-50BF20EC-68A4-4066-B6E2-9C1F2BD4C7FEQ41408430-900E5EA8-311A-4296-83ED-1E8E718B801C
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Basic mechanisms of generalized absence seizures.
@ast
Basic mechanisms of generalized absence seizures.
@en
Basic mechanisms of generalized absence seizures.
@nl
type
label
Basic mechanisms of generalized absence seizures.
@ast
Basic mechanisms of generalized absence seizures.
@en
Basic mechanisms of generalized absence seizures.
@nl
prefLabel
Basic mechanisms of generalized absence seizures.
@ast
Basic mechanisms of generalized absence seizures.
@en
Basic mechanisms of generalized absence seizures.
@nl
P2860
P356
P1433
P1476
Basic mechanisms of generalized absence seizures.
@en
P2093
Snead OC 3rd
P2860
P304
P356
10.1002/ANA.410370204
P577
1995-02-01T00:00:00Z